Develops noninvasive tests for ovarian cancer and endometriosis.
Jun 2026Revenue $170K/yrExpenses $7.07M/yr
No trendCash runway ≈ 1 month from Jun 2026
Figures by year
When will Aspira Women's Health be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $170K and expenses $7.07M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $343K | $8.26M | −$7.91M |
| Dec 2024 | $4.00K | $16.3M | −$16.3M |
| Dec 2023 | $87.0M | $106M | −$18.9M |
| Dec 2022 | $8.18M | $39.3M | −$31.1M |
| Dec 2021 | $6.81M | $39.4M | −$32.6M |
| Dec 2020 | $4.65M | $22.6M | −$18.0M |
| Dec 2019 | $4.54M | $19.8M | −$15.3M |
| Dec 2018 | $3.05M | $14.4M | −$11.3M |
| Dec 2017 | $3.12M | $13.6M | −$10.4M |
| Dec 2016 | $2.64M | $17.6M | −$15.0M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.